Other and Unspecified Pancreas
Primary Site | Histology | Staging Type |
---|---|---|
C253-C254, C257-C259 | 8000-8576, 8940-8950, 8971, 8980-8981 | TNM 7 and Summary Stage |
C253-C254, C257-C259 | 8577-8939, 8951-8970, 8972-8979, 8982-9136, 9141-9582, 9700-9701 | Summary Stage only |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C253 Pancreatic duct C254 Islets of Langerhans C257 Other specified parts of pancreas C258 Overlapping lesion of pancreas C259 Pancreas, NOS **Note 1:** This schema is based on the UICC chapter *Pancreas,* pages 132-135. * Primary sites C257, C258 and C259 are not listed in this chapter of the UICC manual; however, they are included in this schema and TNM staged if appropriate histology criteria are met **Note 2:** For tumors of the islet cells, determine which subsite of the pancreas is involved and use that primary site code and the corresponding schema. * If the subsite cannot be determined, use the general code for Islets of Langerhans, C254, and use the schema for Pancreas, Other and Unspecified **Note 3:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Pancreas: Other and Unspecified* chapter on page 120 of the [SS2000 on-line manual](https://seer.cancer.gov/tools/ssm/ssm2000/SSSM2000-122012.pdf#page=120).Main Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Clinical T | <BLANK> | Yes |
NAACCR #940
tnmClinT |
None | |
Clinical N | <BLANK> | Yes |
NAACCR #950
tnmClinN |
None | |
Clinical M | <BLANK> | Yes |
NAACCR #960
tnmClinM |
None | |
TNM Clin Stage Group | 99 | Yes |
NAACCR #970
tnmClinStageGroup |
None | |
Pathologic T | <BLANK> | Yes |
NAACCR #880
tnmPathT |
None | |
Pathologic N | <BLANK> | Yes |
NAACCR #890
tnmPathN |
None | |
Pathologic M | <BLANK> | Yes |
NAACCR #900
tnmPathM |
None | |
TNM Path Stage Group | 99 | Yes |
NAACCR #910
tnmPathStageGroup |
None | |
SSF1: Carbohydrate Antigen 19-9 (CA 19-9) Lab Value | 988 | No |
NAACCR #2880
csSiteSpecificFactor1 |
None | None |
SSF2: Serum Chromogranin A (CgA) Lab Value | 988 | No |
NAACCR #2890
csSiteSpecificFactor2 |
None | None |
SSF3: Mitotic Count | 988 | No |
NAACCR #2900
csSiteSpecificFactor3 |
None | None |
Additional Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No |
NAACCR #390
dateOfDiagnosis |
None | |
Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | |
Behavior | <BLANK> | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | Yes |
NAACCR #1639
rxSummSystemicSurSeq |
None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | Yes |
NAACCR #1380
rxSummSurgRadSeq |
None | |
Regional Nodes Positive | <BLANK> | Yes |
NAACCR #820
regionalNodesPositive |
None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Derived Version | {{ctx_alg_version}} | None | None | |
Derived SEER Clin Stage Group | 88 |
NAACCR #3610
derivedSeerClinStgGrp |
None | |
Derived SEER Path Stage Group | 88 |
NAACCR #3605
derivedSeerPathStgGrp |
None | |
Derived SEER Combined Stage Group | 88 |
NAACCR #3614
derivedSeerCmbStgGrp |
None | |
Derived SEER Combined T | 88 |
NAACCR #3616
derivedSeerCombinedT |
None | |
Derived SEER Combined N | 88 |
NAACCR #3618
derivedSeerCombinedN |
None | |
Derived SEER Combined M | 88 |
NAACCR #3620
derivedSeerCombinedM |
None | |
Derived SEER Combined T Source | <BLANK> |
NAACCR #3622
derivedSeerCmbTSrc |
None | |
Derived SEER Combined N Source | <BLANK> |
NAACCR #3624
derivedSeerCmbNSrc |
None | |
Derived SEER Combined M Source | <BLANK> |
NAACCR #3626
derivedSeerCmbMSrc |
None |